BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1168625)

  • 1. Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. II. Blocking and unblocking of cytotoxicity.
    Hellström I; Hellström KE
    Int J Cancer; 1975 Jan; 15(1):30-8. PubMed ID: 1168625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells and blocking by serum.
    Hellström I; Hellström KE
    Int J Cancer; 1975 Jan; 15(1):1-16. PubMed ID: 1168624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens.
    Kall MA; Hellström I
    J Immunol; 1975 Mar; 114(3):1083-8. PubMed ID: 1112984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for two factors in sera of tumor-immunized mice which induce specific lymphoid cell-dependent cytotoxicity: IgG2 and a rapidly appearing factor not associated with IgG or IgM.
    Pollack SB; Nelson K
    Int J Cancer; 1975 Aug; 16(2):339-46. PubMed ID: 1150357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cells from chemically induced mouse sarcomas retain tumor-specific transplantation antigenicity during prolonged passage in vitro.
    Walker R; Hellström I; Hellström KE
    Int J Cancer; 1980 Mar; 25(3):345-8. PubMed ID: 7390657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro sensitization to embryonic antigens.
    Friend K; Hellström I; Hellström KE
    Int J Cancer; 1976 Dec; 18(6):843-51. PubMed ID: 992911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lymphocyte-mediated destruction of tumor cells in microcytotoxicity assays seen after addition of inhibitors of protein synthesis.
    Hellström I; Hellström KE; Nepom JT
    Int J Cancer; 1975 Nov; 16(5):830-9. PubMed ID: 1184246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of curative cryosurgery on the tumor-specific immune response of C57 mice.
    Faraci RP; Bagley DH; Marrone JA; Beazley RM
    Cryobiology; 1975 Apr; 12(2):175-9. PubMed ID: 1126183
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor lymph node cells from mice bearing methylcholanthrene-induced sarcomas.
    Indrová M; Bubeník J
    Neoplasma; 1979; 26(4):405-12. PubMed ID: 160510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of tumor outgrowth by tumor-associated blocking factors.
    Hellström KE; Hellström I
    Int J Cancer; 1979 Mar; 23(3):366-73. PubMed ID: 437919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that blocking factors in the sera of multiparous mice are associated with immunoglobulins.
    Tamerius J; Hellström I; Hellström KE
    Int J Cancer; 1975 Sep; 16(3):456-64. PubMed ID: 1176203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mouse rosette forming cells in transplantation immunity].
    Brondz BD; Eliseeva LS; Kotomina IF; Egorova SG
    Tsitologiia; 1974 Jan; 16(1):74-81. PubMed ID: 4142816
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of cyclophosphamide on in vitro correlates of tumor immunity.
    Steele G; Sjögren HO; Ankerst J
    Int J Cancer; 1974 Dec; 14(6):743-52. PubMed ID: 4377004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas.
    Fritze D; Kern DH; Waldman SR; Pilch YH
    Int J Cancer; 1975 Jan; 15(1):116-31. PubMed ID: 1079201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
    Parmiani G; Invernizzi G
    Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific anti-tumor responses of cultured immune spleen cells III. Further characterization of cells which synthesize factors with blocking and antiserum-dependent cellular cytotoxic (ADC) activities.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Oct; 16(4):539-49. PubMed ID: 1080750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers.
    Parmiani G; Carbone G; Lembo R
    Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474
    [No Abstract]   [Full Text] [Related]  

  • 19. The development and specific suppression of concomitant immunity in two syngeneic tumour-host systems.
    Chandradasa KD
    Int J Cancer; 1973 May; 11(3):648-62. PubMed ID: 4598551
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1979; 25(2):137-41. PubMed ID: 456694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.